Invention Grant
- Patent Title: Method for treating uterine fibroids
- Patent Title (中): 治疗子宫肌瘤的方法
-
Application No.: US13622892Application Date: 2012-09-19
-
Publication No.: US08722653B2Publication Date: 2014-05-13
- Inventor: Lynnette Nieman , Andre Ulmann , Diana Blithe , Erin Gainer
- Applicant: Laboratoire HRA-PHARMA , The United States of America, as represented by the Secretary, Department of Health and Human Services
- Applicant Address: FR Paris US DC Washington
- Assignee: Laboratoire HRA-Pharma,The United States of America, as Represented by the Secretary, Department of Health and Human Services
- Current Assignee: Laboratoire HRA-Pharma,The United States of America, as Represented by the Secretary, Department of Health and Human Services
- Current Assignee Address: FR Paris US DC Washington
- Agency: Ascenda Law Group PC
- Main IPC: A61K31/56
- IPC: A61K31/56
Abstract:
The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-N,N-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/or for reducing the size of uterine fibroids.
Public/Granted literature
- US20130023506A1 METHOD FOR TREATING UTERINE FIBROIDS Public/Granted day:2013-01-24
Information query
